UNIVERSAL OMICS
  • Home
  • NUTRITION
  • R&D strategy
  • Our offer
  • About


​Precision Fast-Track
Drug Discovery & Design

In Silico research through in-house software DRUP, for effective and safe design of nutraceutical based medicines.

Helping solve non-communicable diseases resulting from an unbalanced diet (malnutrition), and shortening up to 60% of the time scope and resources needed for pre-clinical phases of drug development.​
​



​KEY MOTIVATORS
​

The Metabolic Net as a key
​for studying NCD
​

Lengthy and costly
​pre-clinical phases

The metabolic net supports brain activity and body functions, and when it fails to do so, Non-Communicable Diseases appear. According to WHO, NCD's are the leading cause of death, becoming 74% of global deaths.

Metabolic complexities make it hard to identify effective therapeutic targets for these NCD. This results on limited tools for multi-target drugs.
​Traditional drug development takes an average of 12 years, and costs $2 billion with just a 12% success rate in clinical trials.

This contrast between effort and reward is explained by the lack of precise methods to validate the efficacy and safety of bio-actives. At the time being, companies cannot produce efficient screenings of nutraceuticals, which costs a great amount of time and resources.

​Drug Discovery is a lengthy and costly process, unable yet to address the complexity of metabolic dysfunctions in non-communicable diseases, leaving critical gaps in innovation and patient outcomes.

OPPORTUNITY

We believe this is our chance to revolutionize pre-clinical research with AI, to capture high-growing segments:
Multi-target drugs addressing metabolic dysfunctions are in demand as they represent a shift from symptom-focused treatments to root-cause solutions.

11.5% CAGR

AI-driven platforms are becoming essential tools for accelerating research and improving success rates.

​

21.36% CAGR

Global healthcare spending driven by the increasing prevalence of chronic diseases and Sources : advancements in precision medicine

5.2% CAGR

What for?

​To address the ineffectiveness of nutraceutical and dietary impact analysis and reduce experimental and clinical trial costs.
  • ​Biomarker discovery
  • Identification of therapeutic targets
  • Nutraceutical and drug design
  • Preclinical studies 
  • Clinical trial design and outcome estimation
  • Predicting effectiveness of nutraceuticals and drugs
  • Molecular analysis of nutrient and dietary impact
  • Comprehensive metabolic pathway analysis
  • Correlation between physiological and clinical states
  • Personalised clinical and nutritional intervention design
Cardiac disease
Obesity
Diabetes
Immunity
Post-COVID19
Integrative platform for health professionals and scientits

​PHARMACY / NUTRA-PHARMACY
NUTRITION
PRECISION and PREDICTIVE MEDICINE  
Democratising the use of Big Data
Picture
  • Saving years in product development
  • Guarantees product effectiveness and quality
  • Minimal risk of side effects and nutraceutical-drug interactions
  • Understanding the medium and long-term impact of diet, supplements and nutraceuticals
  • Savings in research costs
  • ​Personalising nutraceuticals and dietary interventions
Universal application of Quantum Computing
  • To match up the accuracy and speed in machine learning.
  • To help in computational metabolism and successfully map molecules for nutrition and pharmaceutical research.
  • To effectively understand diet and nutraceuticals/drugs and their reactions on humans, and enhance their efficiency dramatically.
Site powered by Weebly. Managed by Hostmonster
  • Home
  • NUTRITION
  • R&D strategy
  • Our offer
  • About